Optima Announces Brand Transition of PAM Group
Optima Health plc
("Optima", the "Company", and, together with its subsidiaries, the "Group")
Optima Health Announces Brand Transition of PAM Group
LONDON, UK, 30 September 2026, Optima Health (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, today announces the transition of the PAM brand, under which all PAM Group brands will migrate to the Optima Health name. This follows Optima’s acquisition of PAM Group in March 2026 and represents a key milestone in the integration of the two businesses.
Since closing the transaction, Optima has focused on integrating core teams, aligning operating structures, and unifying company culture across both organisations. The brand consolidation reflects the completion of that first phase of integration and supports the Company's strategy to build a stronger, best-in-class service delivery model.
Jonathan Thomas, Chief Executive Officer of Optima Health, said: “Bringing our teams together under a common brand gives our clients and our people much greater clarity, and reflects the strength of what these two organisations have built together. Since the acquisition, our teams have worked closely to understand each other's strengths and are well progressed with creating a combined business which sets the standard in our market. I want to thank them for their input and dedication throughout this process. Together, we remain focused on delivering against our strategic objectives and delivering exceptional solutions for our clients.”
-Ends-
About Optima Health
Optima Health is the UK's leading provider of occupational health and wellbeing services, delivering clinically led, technology-driven solutions to organisations across the public and private sectors. With a team of more than 1,600 including 800 clinicians, Optima Health supports millions of employees and operates from a network of more than 50 clinics nationwide.
In addition to its core UK market, Optima Health also operates in Ireland under Optima Health Ireland, providing occupational health services to clients nationwide.
For more information visit www.optimahealth.co.uk
Enquiries
Optima Health
Jonathan Thomas, CEO
Andy Bones, CFO
media@OptimaHealth.co.uk
Panmure Liberum Limited (Nominated Adviser and Co-Broker)
Emma Earl / Will Goode / Mark Rogers / Rupert Dearden
+44 (0)20 3100 2000
Cavendish Capital Markets (Co-Broker)
Geoff Nash / Ben Jeynes / George Lawson / Julian Morse / Michael Johnson / Nigel Birks
+44 (0)20 7220 0500
ICR Healthcare (UK Financial PR Adviser)
Mary-Jane Elliott / Chris Welsh / Lindsey Neville
optimahealth@icrinc.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE